Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Earnings
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Health care industry
Eisai Co Ltd
Biotech and Pharmaceuticals
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Biotechnology
Biogen Inc
US: News
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investing
Biogen Inc
Business News
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
S&P 500
Mad Money
Bank of America Corp
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Biotech and Pharmaceuticals
Earnings
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Ford Motor Co
Investing
Biogen Inc
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Biotech and Pharmaceuticals
Eisai Co Ltd
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Science
Health care industry
Eisai Co Ltd
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Biotech and Pharmaceuticals
Earnings
Eisai Co Ltd
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
5 Things to Know
Airbnb Inc
Business News
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Health care industry
Eisai Co Ltd
Biotech and Pharmaceuticals
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Walt Disney Co
5 Things to Know
Business
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Eisai Co Ltd
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
SAGE Therapeutics Inc
Drug approvals
Business
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Intel Corp
Stock markets
Breaking News: Markets
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Spotify Technology SA
General Motors Co
3M Co
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Health care industry
Wells Fargo & Co
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Morgan Stanley
JPMorgan Chase & Co
5 Things to Know
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health care industry
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Policy
Medicare health plans
U/S/ Economy
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Science
Business
Pharmaceuticals
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
DraftKings Inc
Eisai Co Ltd
Alibaba Group Holding Ltd
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Market Insider
Markets
Finance
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
Pharmaceuticals
Eisai Co Ltd
Asia Markets
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Politics
Biotech and Pharmaceuticals
Policy
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Markets
Market Insider
Morgan Stanley
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Business
World News
Science
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.